HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Genetics of androgen metabolism in women with infertility and hypoandrogenism.

Abstract
Hypoandrogenism in women with low functional ovarian reserve (LFOR, defined as an abnormally low number of small growing follicles) adversely affects fertility. The androgen precursor dehydroepiandrosterone (DHEA) is increasingly used to supplement treatment protocols in women with LFOR undergoing in vitro fertilization. Due to differences in androgen metabolism, however, responses to DHEA supplementation vary between patients. In addition to overall declines in steroidogenic capacity with advancing age, genetic factors, which result in altered expression or enzymatic function of key steroidogenic proteins or their upstream regulators, might further exacerbate variations in the conversion of DHEA to testosterone. In this Review, we discuss in vitro studies and animal models of polymorphisms and gene mutations that affect the conversion of DHEA to testosterone and attempt to elucidate how these variations affect female hormone profiles. We also discuss treatment options that modulate levels of testosterone by targeting the expression of steroidogenic genes. Common variants in genes encoding DHEA sulphotransferase, aromatase, steroid 5α-reductase, androgen receptor, sex-hormone binding globulin, fragile X mental retardation protein and breast cancer type 1 susceptibility protein have been implicated in androgen metabolism and, therefore, can affect levels of androgens in women. Short of screening for all potential genetic variants, hormonal assessments of patients with low testosterone levels after DHEA supplementation facilitate identification of underlying genetic defects. The genetic predisposition of patients can then be used to design individualized fertility treatments.
AuthorsAya Shohat-Tal, Aritro Sen, David H Barad, Vitaly Kushnir, Norbert Gleicher
JournalNature reviews. Endocrinology (Nat Rev Endocrinol) Vol. 11 Issue 7 Pg. 429-41 (Jul 2015) ISSN: 1759-5037 [Electronic] England
PMID25942654 (Publication Type: Journal Article, Review)
Chemical References
  • Androgens
  • Receptors, Androgen
  • Sex Hormone-Binding Globulin
  • Fragile X Mental Retardation Protein
  • Testosterone
  • Dehydroepiandrosterone
  • Aromatase
  • 3-Oxo-5-alpha-Steroid 4-Dehydrogenase
  • Sulfotransferases
  • dehydroepiandrosterone sulfotransferase
Topics
  • 3-Oxo-5-alpha-Steroid 4-Dehydrogenase (genetics)
  • Androgens (deficiency)
  • Animals
  • Aromatase (genetics)
  • Dehydroepiandrosterone (metabolism, therapeutic use)
  • Disease Models, Animal
  • Female
  • Fragile X Mental Retardation Protein (genetics)
  • Genes, BRCA1
  • Humans
  • Infertility, Female (genetics)
  • Ovarian Reserve
  • Polymorphism, Genetic
  • Receptors, Androgen (genetics)
  • Sex Hormone-Binding Globulin (genetics)
  • Sulfotransferases (genetics)
  • Testosterone (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: